Envista Corporation (NVST) continues to suffer due to unfavorable currency movement. Strong competitors also pose a tough challenge for the company. The stock has a Zacks Rank #5 (Strong Sell) currently.Envista has been grappling with deteriorating international trade, with global inflationary pressure leading to a challenging situation related to raw material and labor costs as well as freight charges and rising interest rates. All these are creating significant pressure on the company’s profitability.Addi ...

BREA, Calif., Feb. 26, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) announced today that the Board of Directors and CEO Amir Aghdaei are formally launching a process to determine a successor for CEO. The Board of Directors has formed a search committee and retained an executive search firm to find qualified external candidates to lead the next phase of Envista. This process is expected to be completed this year. Mr. Aghdaei will remain President and CEO until his successor is appointed. "A ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-39054 ENVISTA HOLDINGS CORPORATION (Exact name of registrant as specified in its charter) Delaw ...

Envista Holdings Corporation (NVST) reported fourth-quarter 2023 adjusted earnings per share (EPS) of 29 cents, down 44.2% year over year. The bottom line missed the Zacks Consensus Estimate by 12.1%.The adjustments include charges and benefits related to the amortization of acquired intangible assets, goodwill and intangible asset impairment, among others.The company’s loss from continuing operations was $1.27 in the quarter compared with the year-ago quarter’s EPS of 45 cents.For the full year, adjusted e ...

财务数据和关键指标变化 - 公司第四季度销售额下降2.3%至6.456亿美元,核心销售额下降2% [29] - 第四季度调整后毛利率为52.4%,同比下降380个基点,主要受到销量下降、产品组合不利、VBP导致的价格下降以及汇率不利影响 [30][31] - 第四季度调整后EBITDA利润率为15.6%,同比下降530个基点,主要受到毛利率下降、地理区域组合不利以及在Spark和北美种植体业务的投资 [31] - 第四季度调整后每股收益为0.29美元,上年同期为0.52美元 [32] 各条业务线数据和关键指标变化 - 专业产品与技术分部第四季度核心销售增长4.8%,其中正畸业务增长近15%,种植体业务小幅下降 [32][33][34] - 设备与耗材分部第四季度核心销售下降12.4%,主要受到北美分销渠道的网络攻击事件影响 [36][37][38] - 数字化IOS业务第四季度增长超过30% [39] 各个市场数据和关键指标变化 - 发达市场第四季度销售下降4.8%,其中北美大幅下降,西欧强劲增长 [29] - 新兴市场第四季度销售增长超过9% [29] - 中国市场第四季度销售增长近15%,全年基本持平 [111][112][113] 公司战略和发展方向及行业竞争 - 公司将继续专注于正畸和种植体两大核心业务,提供全面解决方案 [12][47][48][49] - 正畸业务表现强劲,Spark业务有望在2026年翻一番 [12][47] - 种植体业务在北美存在挑战,将采取针对性措施提升增长 [14][15][48][49] - 设备与耗材业务将优化业务重点,提升增长和利润率 [16][38][40] - 公司将持续利用EBS系统优化成本结构,预计2025年可实现1300万美元的结构性成本削减 [50] 管理层对经营环境和未来前景的评论 - 宏观环境仍存在不确定性,地缘政治风险和网络安全攻击等因素对公司业绩产生影响 [9][10] - 预计2024年高端牙科诊疗需求和私人诊所/连锁集团的资本支出将保持谨慎 [45][46] - 公司2024年预计核心销售增长低个位数,调整后EBITDA利润率为16%-17% [46] - 公司将集中精力加速正畸和种植体业务,优化成本结构,为长期价值创造奠定基础 [47][48][49][50] 问答环节重要的提问和回答 问题1 **Elizabeth Anderson 提问** 对2024年利润率指引的疑问,为何大幅下降 [57][58][59][60][61][62][63][64] **Amir Aghdaei 回答** 解释了宏观环境不确定性、产品组合变化、Spark业务快速增长等因素对利润率的影响 [58][59][60] 问题2 **Jeff Johnson 提问** 询问种植体业务在北美的恢复计划 [70][71][72][73][74][79][80] **Amir Aghdaei 回答** 详细阐述了针对北美种植体业务的具体措施,包括客户体验、培训教育、社区建设等方面的改善 [79][80] 问题3 **Erin Wright 提问** 询问公司在季度和年初的需求情况 [87][88][89] **Amir Aghdaei 回答** 说明了中国市场、DSO客户等不同区域和客户群的需求动态 [88][89]

For the quarter ended December 2023, Envista (NVST) reported revenue of $645.6 million, down 2.3% over the same period last year. EPS came in at $0.29, compared to $0.52 in the year-ago quarter.The reported revenue represents a surprise of +2.25% over the Zacks Consensus Estimate of $631.39 million. With the consensus EPS estimate being $0.33, the EPS surprise was -12.12%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine th ...

Fourth Quarter 2023 Earnings Presentation Forward Looking Statements Certain statements in this presentation are “forward-looking” statements within the meaning of the federal securities laws. There are a number of important factors that could cause actual results, developments and business decisions to differ materially from those suggested or indicated by such forward-looking statements and you should not place undue reliance on any such forward-looking statements. These factors include, among other thing ...

公司业绩 - Envista Holdings Corporation (NYSE: NVST)宣布2023年第四季度和全年业绩[1] - 第四季度销售额为6.456亿美元，同比下降2.0%[2] - 第四季度净亏损为2.174亿美元，每股稀释亏损1.27美元，其中包括与商誉和无形资产减值相关的2.583亿美元非现金费用[2] - 2023年全年，Envista实现了调整后的EBITDA利润率为18.1%，并实现了2.236亿美元的自由现金流[3] - 2024年展望：预计核心销售额将增长低个位数，调整后的EBITDA利润率将在16%至17%之间[3] 公司背景 - Envista是一个全球家族，拥有30多个值得信赖的牙科品牌，致力于与专业人士合作改善生活[6] 财务指标 - 公司在2023年的财务报告中列出了非现金项目，包括折旧、摊销、信用损失准备、股票补偿费用等[13] - 公司在2023年的财务指标中显示，毛利为1,474.8百万美元，运营利润为319.2百万美元[14] - 公司在2023年的非GAAP财务指标中显示，调整后的毛利为1,497.9百万美元，调整后的运营利润为482.5百万美元[15] 调整后财务数据 - 公司在2023年的调整后营运利润率中，专业产品和技术部门为15.4%，设备和消耗品部门为19.5%[16] - 公司在2023年的调整后净收入为269.2百万美元，较之前的91.9百万美元有所增长[16] - 调整后的每股稀释收益在2023年第四季度为0.29美元，年度为1.53美元[17] 资产负债表 - Envista的资产负债表显示，截至2023年12月，总资产为65.87亿美元，总负债和股东权益相等[12] 预测和展望 - Envista将在投资者电话会议上讨论季度业绩和2024年展望[5] - 公司在2023年的调整后EBITDA为138.3美元，年度为517.4美元[18] - 自由现金流在2023年第四季度为99.9美元，年度为223.6美元[19]

Analysts on Wall Street project that Envista (NVST) will announce quarterly earnings of $0.33 per share in its forthcoming report, representing a decline of 36.5% year over year. Revenues are projected to reach $632.7 million, declining 4.3% from the same quarter last year.The current level reflects an upward revision of 0.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over ...

Envista Holdings Corporation (NYSE: NVST)成为Women in DSO®的白金行业合作伙伴 - [1] - [2] - [3] - [4]